Page last updated: 2024-10-31

mianserin and Urinary Retention

mianserin has been researched along with Urinary Retention in 3 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Jiang, S	3
Burke, H	3
Hernandez, M	3
Ruth, L	3
Oulis, P	1
Leonardos, A	1
Koulouris, GC	1
Konstantakopoulos, G	1
Lenze, EJ	1

Other Studies

3 other studies available for mianserin and Urinary Retention

Article	Year
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent. The primary care companion for CNS disorders, 2022, 11-17, Volume: 24, Issue:6 Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Re	2022
Mirtazapine-associated urinary retention. The Journal of neuropsychiatry and clinical neurosciences, 2010,Summer, Volume: 22, Issue:3 Topics: Aged, 80 and over; Depressive Disorder, Major; Humans; Male; Mianserin; Mirtazapine; Urinary Retenti	2010
Reversal of SSRI-associated urinary retention with mirtazapine augmentation. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety	2012